Literature DB >> 7954351

The regulatory rep protein of adeno-associated virus binds to sequences within the c-H-ras promoter.

R B Batchu1, R M Kotin, P L Hermonat.   

Abstract

The large rep gene products (rep68 and rep78) of adeno-associated virus (AAV) are pleiotropic effector proteins which not only play a critical role in AAV DNA replication and in the trans-regulation of AAV promotor elements, but are also known for their onco-suppressive functions. We have previously demonstrated that the large AAV rep protein will strongly inhibit expression from the c-H-ras promoter, but not the murine osteosarcoma virus long terminal repeat (MSV-LTR) promoter. To investigate the possibility that rep may physically bind to these promoter sequences, specifically to GCTC motifs, we conducted electrophoretic mobility shift assays (EMSA) with a maltose binding protein-rep chimeric protein, MBP-rep68 delta, and synthetic double stranded DNA substrates of sequences selected from the c-H-ras and MSV-LTR promoters, as well as with the AAV TR. We find that MPB-rep68 delta bound the AAV TR DNA sequence (three motifs) most strongly, followed by the selected c-H-ras DNA sequence (two noninterfering motifs), and most poorly to the MSV-LTR DNA (one motif). These data are consistent with our previous study and suggest a direct mechanism of action for AAV rep inhibition of the c-H-ras promoter. Furthermore, the results suggest that the number of GCTC motifs, when closely associated, affect the affinity of rep binding. Finally, we find that MBP-rep68 delta also binds to the c-H-ras oligomer substrates which have secondary hairpin structures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7954351     DOI: 10.1016/0304-3835(94)90176-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  Mechanism of Rep-mediated adeno-associated virus origin nicking.

Authors:  J R Brister; N Muzyczka
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  The Rep68 protein of adeno-associated virus type 2 stimulates expression of the platelet-derived growth factor B c-sis proto-oncogene.

Authors:  R S Wonderling; R A Owens
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

3.  Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats.

Authors:  J H Ryan; S Zolotukhin; N Muzyczka
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  A chimeric protein containing the N terminus of the adeno-associated virus Rep protein recognizes its target site in an in vivo assay.

Authors:  T Cathomen; D Collete; M D Weitzman
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  AAV Infection: Protection from Cancer.

Authors:  Arun Srivastava; Barrie J Carter
Journal:  Hum Gene Ther       Date:  2016-11-10       Impact factor: 5.695

6.  Site-specific integration of an adeno-associated virus vector plasmid mediated by regulated expression of rep based on Cre-loxP recombination.

Authors:  W Satoh; Y Hirai; K Tamayose; T Shimada
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  The adeno-associated virus type 2 regulatory proteins rep78 and rep68 interact with the transcriptional coactivator PC4.

Authors:  S Weger; M Wendland; J A Kleinschmidt; R Heilbronn
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Studies of the mechanism of transactivation of the adeno-associated virus p19 promoter by Rep protein.

Authors:  Daniel F Lackner; Nicholas Muzyczka
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Transcriptional analysis of the adeno-associated virus integration site.

Authors:  Nathalie Dutheil; Els Henckaerts; Erik Kohlbrenner; R Michael Linden
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

10.  Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters.

Authors:  J C Araujo; J Doniger; F Kashanchi; P L Hermonat; J Thompson; L J Rosenthal
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.